Rentschler Biopharma SE | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Rentschler Biopharma SE

Home
Companies
Rentschler Biopharma SE

BRIEF

published on 02/20/2025 at 13:05, 9 months 12 days ago

Rentschler Biopharma Promotes Patrick Meyer to Global Head of Business Development

CDMO Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
PRESS RELEASE

published on 02/20/2025 at 13:00, 9 months 12 days ago

Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development, emphasizing internal talent and client-focused strategy. Dr. Meyer will lead the global commercial strategy

Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Global Head
BRIEF

published on 01/30/2025 at 14:05, 10 months 5 days ago

Rentschler Biopharma Announces Strategic Realignment of Global Operations

Rentschler Biopharma Strategic Realignment Biologics Focus Stevenage Closure Investment In Growth
PRESS RELEASE

published on 01/30/2025 at 14:00, 10 months 5 days ago

Rentschler Biopharma announces strategic realignment of its global business operations
Rentschler Biopharma SE announces strategic realignment of global business operations, focusing on biologics and ceasing cell and gene therapy operations at Stevenage, UK site to drive innovation and sustainable growth

Innovation Strategic Realignment Biologics Rentschler Biopharma SE Global Business
BRIEF

published on 10/24/2024 at 07:35, 1 year 1 month ago

Rentschler Biopharma's Major Investment in German Headquarters

Investment Rentschler Biopharma Biopharmaceuticals Facility Expansion Laupheim
PRESS RELEASE

published on 10/24/2024 at 07:30, 1 year 1 month ago

Rentschler Biopharma announces largest single investment at its headquarters in Germany
Rentschler Biopharma announces largest single investment at its headquarters in Germany to construct a new buffer media facility, enhancing production efficiency and sustainability

Innovation Investment Germany Rentschler Biopharma Biopharmaceuticals
BRIEF

published on 09/03/2024 at 13:05, 1 year 3 months ago

Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox

Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE

published on 09/03/2024 at 13:00, 1 year 3 months ago

Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies
Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings

Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF

published on 07/11/2024 at 14:05, 1 year 4 months ago

Rentschler Biopharma Unveils New Production Line in Massachusetts

Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
PRESS RELEASE

published on 07/11/2024 at 14:00, 1 year 4 months ago

Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history

Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 32 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 37 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 7 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 2 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 7 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 16 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 56 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 7 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 22 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE